Nan Fung-backed biopharmaceutical company Stealth Bio has filed for an IPO that could bring in almost $87m if it floats at the top of the range.

Stealth BioTherapeutics, a US-based biopharmaceutical company backed by an affiliate of conglomerate Nan Fung, has set the terms for an initial public offering, setting a $12 to $14 range for its shares. The company will issue 6.2 million American Depositary Shares (ADSs), each representing 12 ordinary shares, on the Nasdaq Global Market to raise between…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.